By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celsus Therapeutics 

53 Davies Street

Mayfair  London  W1K 5JH  U.S.A.
Phone: 44-0-20-3322-1321 Fax: 44-0-20-3322-1350


Company News
Celsus Therapeutics (CLTX) Completes Enrollment Of Phase 2 Trial Of MRX-6 Cream 2% In Pediatric Atopic Dermatitis 1/13/2015 6:46:46 AM
Celsus Therapeutics (CLTX) Announces FDA Allowance Of IND For Clinical Development Of MRX-6 Cream In Atopic Dermatitis 1/12/2015 7:03:26 AM
Celsus Therapeutics (CLTX) Announces Upcoming Presentation At Oppenheimer 25th Annual Healthcare Conference 12/3/2014 4:02:45 PM
Celsus Therapeutics (CLTX) Announces First Patient Enrolled In Phase 2 Trial Of MRX-6 In Pediatric Atopic Dermatitis 8/6/2014 8:00:09 AM
Celsus Therapeutics (CLTX) Receives Approval From The Ministry Of Health Of Israel For Phase 2 Trial Of MRX-6 In Pediatric Atopic Dermatitis Patients 6/17/2014 8:52:49 AM
Celsus Therapeutics (CLTX) Announces Formation Of New Dermatology Scientific Advisory Board 4/7/2014 9:26:57 AM
Celsus Therapeutics (CLTX) To Present At The 13th Annual Needham Healthcare Conference 4/1/2014 9:11:17 AM
Celsus Therapeutics (CLTX) Provides Year End 2013 Financial Results And Corporate Highlights 3/25/2014 9:04:32 AM
Celsus Therapeutics (CLTX) Provides Update On MRX-6 From FDA Pre-IND Meeting 3/12/2014 9:15:20 AM
Celsus Therapeutics (CLTX) Announces The Closing Of $9.2 Million Public Offering And Full Exercise Of Underwriter's Option To Purchase Additional Adss 2/6/2014 9:22:24 AM